首页 > 最新文献

Bibliotheca haematologica最新文献

英文 中文
Statistics on underlying and causative diseases of DIC in Japan: a cooperative study. 日本DIC的基础和病因统计:一项合作研究。
Pub Date : 1983-01-01 DOI: 10.1159/000408443
M Matsuda, N Aoki
{"title":"Statistics on underlying and causative diseases of DIC in Japan: a cooperative study.","authors":"M Matsuda, N Aoki","doi":"10.1159/000408443","DOIUrl":"https://doi.org/10.1159/000408443","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000408443","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17721691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease. 恶性疾病患者纤维蛋白肽a (FPA)水平与纤维蛋白原动力学的关系
Pub Date : 1983-01-01 DOI: 10.1159/000408457
Y Yoda, H Nakamura, T Abe

The relationship between FPA level and fibrinogen turnover rate as well as fibrinolytic activity was studied in 18 patients with malignant diseases. It was found that the FPA levels were significantly elevated and were correlated with fibrinogen turnover rate (r = 0.74, p less than 0.001) and FDP (r = 0.58, p less than 0.02). The estimated FPA turnover rate was also correlated with fibrinogen turnover rate (r = 0.70, p less than 0.001). These results suggest that fibrinogen catabolism in patients with malignant disease is related to thrombin proteolysis. However, ratios of 1/2 FPA turnover rate to fibrinogen turnover rate suggest that intravascular thrombin proteolysis is not the major determinant of fibrinogen catabolism. It is suspected that extravascular thrombin proteolysis is responsible for the elevation of plasma FPA level which is correlated with acceleration of fibrinogen catabolism.

本文对18例恶性肿瘤患者FPA水平与纤维蛋白原周转率及纤溶活性的关系进行了研究。FPA水平显著升高,并与纤维蛋白原周转率(r = 0.74, p < 0.001)和FDP (r = 0.58, p < 0.02)相关。估计的FPA周转率也与纤维蛋白原周转率相关(r = 0.70, p < 0.001)。这些结果提示恶性疾病患者纤维蛋白原分解代谢与凝血酶蛋白水解有关。然而,1/2 FPA周转率与纤维蛋白原周转率的比值表明,血管内凝血酶蛋白水解并不是纤维蛋白原分解代谢的主要决定因素。推测血管外凝血酶蛋白水解是血浆FPA水平升高的原因,而FPA水平升高与纤维蛋白原分解代谢加速有关。
{"title":"Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.","authors":"Y Yoda,&nbsp;H Nakamura,&nbsp;T Abe","doi":"10.1159/000408457","DOIUrl":"https://doi.org/10.1159/000408457","url":null,"abstract":"<p><p>The relationship between FPA level and fibrinogen turnover rate as well as fibrinolytic activity was studied in 18 patients with malignant diseases. It was found that the FPA levels were significantly elevated and were correlated with fibrinogen turnover rate (r = 0.74, p less than 0.001) and FDP (r = 0.58, p less than 0.02). The estimated FPA turnover rate was also correlated with fibrinogen turnover rate (r = 0.70, p less than 0.001). These results suggest that fibrinogen catabolism in patients with malignant disease is related to thrombin proteolysis. However, ratios of 1/2 FPA turnover rate to fibrinogen turnover rate suggest that intravascular thrombin proteolysis is not the major determinant of fibrinogen catabolism. It is suspected that extravascular thrombin proteolysis is responsible for the elevation of plasma FPA level which is correlated with acceleration of fibrinogen catabolism.</p>","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000408457","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17721692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical significance of intravascular coagulation. 血管内凝血的临床意义。
Pub Date : 1983-01-01 DOI: 10.1159/000408448
D G McKay

In conclusion, intravascular coagulation in the microcirculation is an important intermediary mechanism of disease. It is always secondary to a primary etiologic factor, but often accounts for some of the major pathological and clinical manifestations of many diseases. It may be acute or chronic, local or disseminated, and is a major factor in the development of hypercoagulable blood with secondary thrombosis of large veins or arteries. Comprehension of its biological significance requires knowledge of the pathological anatomy as well as the physiological and biochemical changes in the blood and vasomotor apparatus in each individual disease or patient.

总之,微循环血管内凝血是疾病发生的重要中介机制。它总是继发于原发性病因,但往往是许多疾病的一些主要病理和临床表现的原因。它可以是急性的或慢性的,局部的或弥散性的,并且是发展高凝血伴继发性大静脉或动脉血栓形成的主要因素。要理解其生物学意义,需要了解病理解剖学,以及每种疾病或患者血液和血管舒缩装置的生理生化变化。
{"title":"Clinical significance of intravascular coagulation.","authors":"D G McKay","doi":"10.1159/000408448","DOIUrl":"https://doi.org/10.1159/000408448","url":null,"abstract":"<p><p>In conclusion, intravascular coagulation in the microcirculation is an important intermediary mechanism of disease. It is always secondary to a primary etiologic factor, but often accounts for some of the major pathological and clinical manifestations of many diseases. It may be acute or chronic, local or disseminated, and is a major factor in the development of hypercoagulable blood with secondary thrombosis of large veins or arteries. Comprehension of its biological significance requires knowledge of the pathological anatomy as well as the physiological and biochemical changes in the blood and vasomotor apparatus in each individual disease or patient.</p>","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000408448","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17424683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
The clinical pathology of intravascular coagulation. 血管内凝血的临床病理。
Pub Date : 1983-01-01 DOI: 10.1159/000408462
E J Bowie, C A Owen

A variety of mechanisms may cause intravascular coagulation. Fibrinolysis is nearly always secondary to the initial clotting. In the acute form, ICF is characterized by depletion of platelets and several coagulation factors together with active fibrinolysis. There is a decrease in Factors V and VIII because they are sensitive to coagulation. The stable coagulation factors may be decreased as well because after activation they are removed from the circulation by the liver and reticuloendothelial system. Severe bleeding is the usual accompaniment of the acute syndrome, which may also occur in cancer and infection of all types. The acute syndrome may also occur in prolonged, extensive operations, after transfusion of incompatible blood, heat stroke, acute injury, certain snake bites, and with the administration of certain drugs. The chronic syndrome of intravascular coagulation is much more common and is associated with many diseases, including collagen diseases or immune diseases and malignancy. Many patients with chronic intravascular coagulation have normal or even increased levels of coagulation factors, and these patients have no unusual bleeding. The diagnosis depends on the demonstration of circulating complex of "soluble" fibrin revealed by the ethanol gel and protamine sulfate gelation tests. The secondary fibrinolysis results in elevation of FSP. Many laboratories are investigating the use of other procedures in the diagnosis of intravascular coagulation, including fibrinopeptides A and B, the VIII:C VIIIR:AG ratio, antithrombin III, PF 4, beta-thromboglobulin, D dimer, urinary FSP, and fibrinogen chromatography.

多种机制可引起血管内凝血。纤维蛋白溶解几乎总是继发于最初的凝血。在急性形式中,ICF的特征是血小板和几种凝血因子的消耗以及活跃的纤维蛋白溶解。因子V和因子VIII降低,因为它们对凝血很敏感。稳定凝血因子也可能减少,因为激活后它们被肝脏和网状内皮系统从循环中清除。严重出血通常伴随着急性综合征,也可能发生在癌症和所有类型的感染中。急性综合征也可发生在长时间的大范围手术、输错血、中暑、急性损伤、某些蛇咬伤和服用某些药物后。血管内凝血的慢性综合征更为常见,并与许多疾病有关,包括胶原蛋白疾病或免疫疾病和恶性肿瘤。许多慢性血管内凝血患者凝血因子水平正常甚至升高,这些患者没有异常出血。诊断依赖于乙醇凝胶和硫酸鱼精蛋白凝胶试验显示的“可溶性”纤维蛋白循环复合体。继发性纤维蛋白溶解导致FSP升高。许多实验室正在研究其他方法在血管内凝血诊断中的应用,包括纤维蛋白肽A和B、VIII:C: VIII: AG比值、抗凝血酶III、pf4、β -血栓球蛋白、D二聚体、尿FSP和纤维蛋白原色谱。
{"title":"The clinical pathology of intravascular coagulation.","authors":"E J Bowie,&nbsp;C A Owen","doi":"10.1159/000408462","DOIUrl":"https://doi.org/10.1159/000408462","url":null,"abstract":"<p><p>A variety of mechanisms may cause intravascular coagulation. Fibrinolysis is nearly always secondary to the initial clotting. In the acute form, ICF is characterized by depletion of platelets and several coagulation factors together with active fibrinolysis. There is a decrease in Factors V and VIII because they are sensitive to coagulation. The stable coagulation factors may be decreased as well because after activation they are removed from the circulation by the liver and reticuloendothelial system. Severe bleeding is the usual accompaniment of the acute syndrome, which may also occur in cancer and infection of all types. The acute syndrome may also occur in prolonged, extensive operations, after transfusion of incompatible blood, heat stroke, acute injury, certain snake bites, and with the administration of certain drugs. The chronic syndrome of intravascular coagulation is much more common and is associated with many diseases, including collagen diseases or immune diseases and malignancy. Many patients with chronic intravascular coagulation have normal or even increased levels of coagulation factors, and these patients have no unusual bleeding. The diagnosis depends on the demonstration of circulating complex of \"soluble\" fibrin revealed by the ethanol gel and protamine sulfate gelation tests. The secondary fibrinolysis results in elevation of FSP. Many laboratories are investigating the use of other procedures in the diagnosis of intravascular coagulation, including fibrinopeptides A and B, the VIII:C VIIIR:AG ratio, antithrombin III, PF 4, beta-thromboglobulin, D dimer, urinary FSP, and fibrinogen chromatography.</p>","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000408462","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17480383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Incidence and clinicopathological significance of DIC in autopsy cases. 尸体解剖病例DIC的发生率及临床病理意义。
Pub Date : 1983-01-01 DOI: 10.1159/000408449
K Tanaka, T Imamura

Disseminated intravascular coagulation (DIC) was examined pathologically in 4906 consecutive autopsy cases during the last 11 years. The cases having pathologically confirmed DIC showing microthrombi in three or more organs were 88. Of the underlying diseases for these cases, malignant tumor was found in 40 cases and diseases of hematopoietic organs in 19. Of the cases with malignant tumor, 11 had gastric cancer, 7 had lung cancer, and 4 had pancreatic cancer. Thirty-three of the 40 cases with malignant tumor showed metastasis in two or more organs. Cases with pathologically confirmed or suspected DIC that had microthrombi in one or more organs were 319. As for the incidence of pathologically suggestive DIC in each disease, the incidence of malignant tumor was 7.3% and that for diseases of the hematopoietic organ was 10.6%. Infection is an important underlying condition, especially gram-negative bacillus septicemia which may play an important role in the development of DIC. An increase in the number of white blood cells appears to be one of the causative conditions of DIC. Kidney is involved most frequently by the deposition of microthrombi, and 27 out of 88 cases show ischemic lesions induced by intravascular coagulation. There were 109 cases having clinically diagnosed or suspected DIC, but 67 cases showed no microthrombus formation. On the other hand, 63 among 4,797 cases with clinically unsuspected DIC revealed microthrombus formation in three or more organs by the postmortem examination.

弥散性血管内凝血(DIC)病理检查4906连续尸检病例在过去11年。病理证实的DIC有3个或更多器官出现微血栓的病例88例。其中,恶性肿瘤40例,造血器官病变19例。恶性肿瘤中胃癌11例,肺癌7例,胰腺癌4例。40例恶性肿瘤中有33例出现两个或两个以上器官的转移。病理证实或怀疑DIC的病例中,有一个或多个器官有微血栓的有319例。病理提示DIC在各疾病的发生率中,恶性肿瘤的发生率为7.3%,造血器官疾病的发生率为10.6%。感染是DIC的重要基础条件,特别是革兰氏阴性杆菌败血症可能在DIC的发展中起重要作用。白细胞数量的增加似乎是DIC的病因之一。微血栓沉积最常累及肾脏,88例中有27例显示血管内凝血引起的缺血性病变。109例临床诊断或疑似DIC, 67例未见微血栓形成。另一方面,在4797例临床未怀疑DIC的病例中,63例尸检发现三个或更多器官有微血栓形成。
{"title":"Incidence and clinicopathological significance of DIC in autopsy cases.","authors":"K Tanaka,&nbsp;T Imamura","doi":"10.1159/000408449","DOIUrl":"https://doi.org/10.1159/000408449","url":null,"abstract":"<p><p>Disseminated intravascular coagulation (DIC) was examined pathologically in 4906 consecutive autopsy cases during the last 11 years. The cases having pathologically confirmed DIC showing microthrombi in three or more organs were 88. Of the underlying diseases for these cases, malignant tumor was found in 40 cases and diseases of hematopoietic organs in 19. Of the cases with malignant tumor, 11 had gastric cancer, 7 had lung cancer, and 4 had pancreatic cancer. Thirty-three of the 40 cases with malignant tumor showed metastasis in two or more organs. Cases with pathologically confirmed or suspected DIC that had microthrombi in one or more organs were 319. As for the incidence of pathologically suggestive DIC in each disease, the incidence of malignant tumor was 7.3% and that for diseases of the hematopoietic organ was 10.6%. Infection is an important underlying condition, especially gram-negative bacillus septicemia which may play an important role in the development of DIC. An increase in the number of white blood cells appears to be one of the causative conditions of DIC. Kidney is involved most frequently by the deposition of microthrombi, and 27 out of 88 cases show ischemic lesions induced by intravascular coagulation. There were 109 cases having clinically diagnosed or suspected DIC, but 67 cases showed no microthrombus formation. On the other hand, 63 among 4,797 cases with clinically unsuspected DIC revealed microthrombus formation in three or more organs by the postmortem examination.</p>","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000408449","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17722483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Rheology and vasomotion: a validation of hemodilution as a rational therapeutic maneuver. 流变学和血管舒缩:血液稀释作为一种合理治疗手法的验证。
Pub Date : 1981-01-01 DOI: 10.1159/000402216
D H Lewis, H Schmid-Schönbein
{"title":"Rheology and vasomotion: a validation of hemodilution as a rational therapeutic maneuver.","authors":"D H Lewis,&nbsp;H Schmid-Schönbein","doi":"10.1159/000402216","DOIUrl":"https://doi.org/10.1159/000402216","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000402216","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18350048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hemodilution in cardiac surgery. 心脏手术中的血液稀释。
Pub Date : 1981-01-01 DOI: 10.1159/000402241
P Lilleaasen
{"title":"Hemodilution in cardiac surgery.","authors":"P Lilleaasen","doi":"10.1159/000402241","DOIUrl":"https://doi.org/10.1159/000402241","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000402241","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18350065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hemodilution in coronary bypass operations. 冠状动脉旁路手术中的血液稀释。
Pub Date : 1981-01-01 DOI: 10.1159/000402239
W P Klövekorn, J Richter, F Sebening
{"title":"Hemodilution in coronary bypass operations.","authors":"W P Klövekorn,&nbsp;J Richter,&nbsp;F Sebening","doi":"10.1159/000402239","DOIUrl":"https://doi.org/10.1159/000402239","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000402239","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18025976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Normovolemic and hypervolemic hemodilution in cerebrovascular ischemia. 脑血管缺血的等容性和高容性血液稀释。
Pub Date : 1981-01-01 DOI: 10.1159/000402217
U Gottstein
{"title":"Normovolemic and hypervolemic hemodilution in cerebrovascular ischemia.","authors":"U Gottstein","doi":"10.1159/000402217","DOIUrl":"https://doi.org/10.1159/000402217","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000402217","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17239505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies. 除纤剂:在对照研究中对血液流变学、血流和血管疾病的影响。
Pub Date : 1981-01-01 DOI: 10.1159/000402231
G D Lowe
{"title":"Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies.","authors":"G D Lowe","doi":"10.1159/000402231","DOIUrl":"https://doi.org/10.1159/000402231","url":null,"abstract":"","PeriodicalId":75590,"journal":{"name":"Bibliotheca haematologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000402231","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18087364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Bibliotheca haematologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1